Identification of subgroup effect with an individual participant data meta-analysis of randomised controlled trials of three different types of therapist-delivered care in low back pain by Hee, S. W. et al.
RESEARCH ARTICLE Open Access
Identification of subgroup effect with an
individual participant data meta-analysis of
randomised controlled trials of three
different types of therapist-delivered care
in low back pain
Siew Wan Hee1, Dipesh Mistry2* , Tim Friede3, Sarah E. Lamb4, Nigel Stallard1, Martin Underwood2,5,
Shilpa Patel2 and On behalf of the Repository Group
Abstract
Background: Proven treatments for low back pain, at best, only provide modest overall benefits. Matching people
to treatments that are likely to be most effective for them may improve clinical outcomes and makes better use of
health care resources.
Methods: We conducted an individual participant data meta-analysis of randomised controlled trials of three types
of therapist delivered interventions for low back pain (active physical, passive physical and psychological
treatments). We applied two statistical methods (recursive partitioning and adaptive risk group refinement) to
identify potential subgroups who might gain greater benefits from different treatments from our individual
participant data meta-analysis.
Results: We pooled data from 19 randomised controlled trials, totalling 9328 participants. There were 5349 (57%)
females with similar ratios of females in control and intervention arms. The average age was 49 years (standard
deviation, SD, 14).
Participants with greater psychological distress and physical disability gained most benefit in improving on the
mental component scale (MCS) of SF-12/36 from passive physical treatment than non-active usual care (treatment
effects, 4.3; 95% confidence interval, CI, 3.39 to 5.15). Recursive partitioning method found that participants with
worse disability at baseline gained most benefit in improving the disability (Roland Morris Disability Questionnaire)
outcome from psychological treatment than non-active usual care (treatment effects, 1.7; 95% CI, 1.1 to 2.31).
Adaptive risk group refinement did not find any subgroup that would gain much treatment effect between
psychological and non-active usual care. Neither statistical method identified any subgroups who would gain an
additional benefit from active physical treatment compared to non-active usual care.
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Conclusions: Our methodological approaches worked well and may have applicability in other clinical areas.
Passive physical treatments were most likely to help people who were younger with higher levels of disability and
low levels of psychological distress. Psychological treatments were more likely to help those with severe disability.
Despite this, the clinical importance of identifying these subgroups is limited. The sizes of sub-groups more likely to
benefit and the additional effect sizes observed are small. Our analyses provide no evidence to support the use of
sub-grouping for people with low back pain.
Keywords: Low back pain, Stratification, Subgroups, IPD, Therapist delivered interventions, Physical interventions,
Psychological interventions
Background
Low back pain (LBP) is the leading cause of disability
globally, with an increasing burden [1]. Stratified care,
delivering the right treatment to the right person at the
right time, could potentially reduce this burden [2, 3].
Conducting randomised controlled trials (RCTs) to iden-
tify subgroups who benefit from particular treatments to
inform stratification is challenging. Typically, in the UK,
a good quality RCT costs £1-2 m and takes up to 5
years.
The standard approach to subgroup identification is to
measure effect moderation of baseline variables in an
interaction analysis [4]. The interaction analysis esti-
mates the response effect where the baseline characteris-
tic of interest moderates the treatments. Substantially
larger numbers are needed to show these moderation ef-
fects than are needed to show main treatment effects of
the same magnitude [5]. A systematic review of sub-
group analyses in LBP trials found the overall quality to
be poor [6] with few studies having statistical power to
detect realistic moderation effects. Furthermore, stand-
ard approaches consider one factor at a time. Combina-
tions of factors might identify clinically recognisable
subgroups with larger moderation effects. The use of in-
dividual participant data (IPD) meta-analysis of RCTs
may provide power to identify subgroups defined by
multiple factors benefiting most from particular
treatments.
A 2019 IPD meta-analysis (m = 27 trials, n = 3514 par-
ticipants) of exercise therapy for low back pain (LBP)
found a small number of statistically significant charac-
teristics that moderated treatment outcomes [7].
As part of a National Institute for Health Research
programme grant we developed a repository of data
from RCTs of therapist delivered active physical, passive
physical and psychological interventions for LBP pub-
lished between 1999 and 2012 [8, 9]. For brevity, the
term therapist-delivered interventions include non-
pharmacological interventions delivered by therapists in-
cluding physiotherapists, occupational therapists, chiro-
practors, osteopaths and psychologists. Our aim was to
understand which participants are most likely to benefit
from which treatment approaches to help improve the
clinical and cost effectiveness of future LBP treatments.
In this programme of work, we developed two different
approaches to subgroup identification and used these
approaches to estimate the magnitude of the identifiable
subgroup effects. This paper presents the results of ap-
plying these two statistical approaches.
Methods
Full details of the programme are published [9] else-
where. Here we summarise part of the programme of
work. Ethical approval was granted by Oxford Central
REC (11/SC/0232).
Identifying the data and developing a pooled repository
We did a systematic review to identify potential modera-
tors to apply to our dataset. The studies identified in this
review formed the basis of the trials we sought to in-
clude in this study [10]. In this review MEDLINE,
EMBASE, Web of Science and Citation Index and
Cochrane Controlled Trials Register (CENTRAL) data-
bases were searched using the terms ‘low back pain’
combined with ‘trial’, ‘observational’, ‘cohort’ and ‘pro-
spective studies’. Two independent reviewers assessed
risk of bias based on these criteria: method of random-
isation, allocation concealment, incomplete outcome
data, selective outcome reporting, and other sources of
bias. We searched the original search output for rando-
mised control trials that had interventions being deliv-
ered by a therapist and had a sample size > 179. We
invited investigators of the trials identified to share trial
data with us. We focussed on recently published larger
trials to ensure we included higher quality studies, where
data would be more likely to be available. Including large
numbers of small studies would have substantially in-
creased work needed to prepare data for inclusion in our
database. Having said this we were offered data from a
few smaller studies which we decided to include to im-
prove the statistical power of our analysis. Full details of
our approach to obtaining data and developing and
managing the repository are published elsewhere [8].
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As trials had a range of therapist-delivered and control
interventions we grouped this to allow meaningful ana-
lysis. Using a similar approach to the American Pain So-
ciety/American College of Physicians guidelines of
grouping non-pharmacological interventions [11],
groups were: control (non-active usual care), sham con-
trol (sham acupuncture, electrotherapy, advice/educa-
tion, mock transcutaneous electrical nerve stimulation),
active physical (exercise and graded activity), passive
physical (individual physiotherapy, manual therapy, acu-
puncture) and psychological (advice/education, psycho-
logical therapy) [8, 9].
As trials had different follow-up times, we classified
follow-up into short- (2 and 3 months), mid- (6 months)
and long-term (12 months post randomisation). We clas-
sified the 32 patient reported outcome measures
(PROMs) used into physical disability, pain, psycho-
logical distress and non-utility quality of life. As has pre-
viously been shown, LBP disability measures cannot be
mapped into a single outcome [12], analyses were there-
fore only performed on measures common to more than
one trial. We have presented the response for each clin-
ical outcome measurement as the change from baseline
to the follow-up time point with a positive score repre-
senting an improvement. Individual items (if available)
were used to obtain the composite score otherwise, the
original individual composite scores were used.
Descriptive analysis
We summarised categorical data as frequency and per-
centage, and continuous data as mean and standard de-
viation (SD), by treatment arm; control (non-active usual
care and sham) and intervention (active physical, passive
physical, psychological, and combination). Our main
analyses were based on complete case analysis with
missing data due to non-responders or withdrawals not
imputed. Analyses were performed on IPD from at least
two trials so as not to replicate original analyses.
Identification of moderators
We identified potential moderators in two ways. Firstly,
from our systematic review identifying potential treat-
ment moderators (factors measured pre-randomisation
indicating who benefits most and least from a treatment)
[10]. Secondly, including IPD from all RCTs in a single
mixed-effects meta-analysis model for each follow-up
time with moderators declared statistically significant at
the two-sided 5% or weakly significant at the two-sided
20% level [13].
Approaches to subgroup identification
We applied two approaches to identification of sub-
groups: Recursive Partitioning (RP) [14] and Adaptive
Refinement by Directed Peeling (ARDP) [15]. Both aim
to identify subgroups of participants with treatment ef-
fect larger than for other participants, by considering
subgroups defined by ranges of values for sets of moder-
ators. The RP method creates subgroups by successively
splitting the population to build up a subgroup. It uti-
lises a splitting criterion to create binary splits of the co-
variate space thus forming a tree-like structure. This
splitting criterion isthe p-value of the subgroup effect
(treatment by covariate interaction) which is estimated
using a mixed-effects model to account for the between
trial heterogeneity.
The ARDP method starts with the whole population
then removes parts of it, thereby increasing the observed
treatment effect in the remaining subgroups. The criter-
ion for optimisation is based on the interaction between
treatment and subgroup which allows for between-trial
heterogeneity. This method splits categorical covariates
using each of its categories, for example, sex would be
split into male and female. Therefore, categorical covari-
ates with three or fewer categories would cause the
method to remove a large proportion of participants at
each stage, an unappealing feature. Covariates with three
or fewer categories were not included in this analysis.
To establish proof of principle for our novel methods
we first ran our analyses on the overall dataset before
running our main analyses for the pairwise comparisons
of active physical, passive physical and psychological
treatments against control. It is these three distinct com-
parisons that are the clinically outputs from this study.
We present our methodological steps in some detail to
introduce the reader to our methodological approach.
Results
Descriptive and one-step meta-analysis
We collected data from 9328 participants from 19 trials
(Tables 1 and 2). We identified three broad treatment
types within the data repository for which we wish to ex-
plore potential moderators; (i) active physical, ii) passive
physical, iii) psychological treatments. Control arms in-
cluded non-active usual care and sham intervention.
There were 5349 (57%) females with similar ratios of
females in control and intervention arms. The average
age was 49 years (standard deviation, SD, 14). The age
range is slightly different across treatment arms due to
different inclusion criteria of the trials [9].
The most frequently used PROM for physical disability
was the Roland Morris Disability Questionnaire
(RMDQ), (m = 14 trials, n = 4710 participants). This was
followed by the disability score domain in Chronic Pain
Grade (CPG-DS) (m = 4, n = 3328), the Hannover func-
tional ability questionnaire for measuring back-pain re-
lated functional limitations (FFbHR) (m = 3, n = 4176)
and the patient specific functional scale (PSFS) (m = 3,
n = 667) (Additional file 1: Appendix 1). The physical
Hee et al. BMC Musculoskeletal Disorders          (2021) 22:191 Page 3 of 13
Table 1 Included trials
Given name of trial Country Number of participants Grouping of treatments Interventions tested
Witt [16] Germany 3093 Passive physical Acupuncture
Control Usual/GP care control
UK BEAM [17] United Kingdom 1334 Active physical Exercise
Passive physical Manipulation
Combination Combination (exercise + manipulation)
Control Usual/GP care control
Haake [18] Germany 1163 Passive physical Acupuncture
Control Usual/GP care control
Sham control Sham acupuncture
BeST [19] United Kingdom 701 Psychological Psychological plus exercise/activities
Control Usual/GP care control
Keele [20] United Kingdom 402 Passive physical Manipulation
Psychological Psychological
Brinkhaus [21] Germany 298 Passive physical Acupuncture
Control Usual/GP care control
Sham control Sham acupuncture
Dufour [22] Denmark 286 Passive physical Individual physiotherapy
Active physical Exercise
Pengel [23] Australia 260 Active physical Exercise
Psychological Advice/education
Combination Combination (exercise + education)
Sham control Sham electrotherapy + education
YACBAC [24] United Kingdom 241 Passive physical Acupuncture
Control Usual/GP care control
Hancock [25] Australia 240 Passive physical Manipulation
Sham control Sham electrotherapy
Von Korff BIA [26] United States of America 240 Psychological Psychological
Control Usual/GP care control
HullExPro [27] United Kingdom 237 Passive physical Individual physiotherapy
Active physical Exercise
Von Korff SC2 [28] United States of America 226 Psychological Psychological
Control Usual/GP care control
Smeets [29] The Netherlands 223 Active physical Exercise
Active physical Graded activity
Combination Combination (education + graded activity)
Control Usual/GP care control
Cecchi [30] Italy 210 Passive physical Individual physiotherapy
Passive physical Manipulation
Psychological Advice/education
York BP [31] United Kingdom 187 Active physical Exercise
Control Usual/GP care control
Macedo [32] Australia 172 Psychological Advice/education
Active physical Graded activity
Carlsson [33] Sweden 50 Passive physical Acupuncture
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Table 1 Included trials (Continued)
Given name of trial Country Number of participants Grouping of treatments Interventions tested
Sham control Sham TENS
Kennedy [34] United Kingdom 48 Passive physical Acupuncture
Sham control Sham TENS
Table 2 Demographic details
Characteristics Controlc
(No. of trials













No. of trials, m: no. of participants, n 14 3573 19 5753 19 9326
Mean (SD) 50.13 (13.77) 48.18 (13.9) 48.92 (13.88)
Sex
No. of trials, m 14 19 19
Female (%) 2053 (57.47) 3296 (57.28) 5349 (57.36)
Male (%) 1519 (42.53) 2458 (42.72) 3977 (42.64)
Ethnicity
No. of trials, m 4 5 5
White (%) 478 (89.35) 891 (88.66) 1369 (88.9)
Mixed (%) 3 (0.56) 4 (0.40) 7 (0.45)
Black (%) 21 (3.93) 26 (2.59) 47 (3.05)
Asian (Indian, Pakistani, Bangladeshi, others) (%) 17 (3.18) 44 (4.38) 61 (3.96)
Chinese (%) 1 (0.19) 2 (0.20) 3 (0.19)
Others (%) 15 (2.80) 38 (3.78) 53 (3.44)
Smoking status
No. of trials, m 2 6 6
No (%) 123 (74.10) 763 (64.39) 886 (65.58)
Yes (%) 43 (25.90) 422 (35.61) 465 (34.42)
Employment status
No. of trials, m 7 11 11
Full time employment (%) 489 (53.80) 1256 (49.68) 1745 (50.77)
Part time employment (%) 190 (20.90) 442 (17.48) 632 (18.39)
No employment (%) 230 (25.30) 830 (32.83) 1060 (30.84)
BMI
No. of trials, m: no. of participants, n 2 915 5 1189 5 2104
Mean (SD) 26.44 (4.60) 1189 (26.67) 26.57 (4.73)
am, number of trials
bn, number of participants
cControl arm includes best usual care and sham treatments. Four trials did not have control arm
dIntervention arm includes active physical, passive physical, psychological and combination
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disability, functional limitation and pain mean scores be-
tween control and intervention arms at baseline were
very similar. The mean RMDQ score was 9.9 (SD, 5.1;
where a maximum score of 24 was worst), CPG-DS was
50.2 (SD, 22; where a maximum score of 100 was worst),
and FFbHR was 57.6 (SD, 20.5; where a maximum score
of 100 was best). Most trials measured psychological dis-
tress but the wide variety patient reported outcome mea-
sures (PROMs) made direct comparisons impossible.
In our overall one-step meta-analysis (MA) interven-
tion was better than control in improving most out-
comes in the short-term (Fig. 1 & Supplementary
Table 1). As treatment effects at mid and long-term
were generally not statistically significant, we only ex-
plored potential moderators for short-term follow-up.
Identification of moderators
We included potential effect moderators identified from
our systematic review [10] and one-step MA in the
mixed effects model. In our overall short-term analysis,
we found few potential moderator effects (Fig. 2 & Sup-
plementary Table 2). Overall, the baseline value of a
measure moderated treatment effects on that measure;
FFbHR at baseline moderates the effect on FFbHR, phys-
ical component scale (PCS) at baseline moderates the ef-
fect on SF-12/36 PCS, and mental component scale
(MCS) at baseline moderates the effect on SF-12/36
MCS. Age, gender, LBP disability and severity (FFbHR,
RMDQ, Pain and PCS), psychological state (MCS, anx-
iety, catastrophising and coping) were at least weakly
significant in one or more moderator analysis and were
considered for further subgroup analysis.
Recursive partitioning: overall comparison
Analyses included between 1339 and 5208 people (from
two to seven trials; Additional file 1: Appendix 2). We
identified subgroups for three of the short-term outcome
measures; FFbHR, SF-12/36 MCS and SF-12/36 PCS.
Those with more back pain disability at baseline
(FFbHR≤54.2) benefitted more from any therapist-
delivered intervention at short-term follow-up than
those with FFbHR> 54.2 with treatment effects of 11.3
(95% confidence interval, CI, 9.38 to 13.23) and 6.6 (95%
CI, 5.46 to 7.78) respectively, when measured by the
FFbHR (Fig. 3). However, those with greater back pain
disability (FFbHR≤54.2) and younger (age ≤ 60) gained
Fig. 1 One-step meta-analysis: Estimated difference between control (non-active usual care and sham) and all intervention treatments for each
outcome with its 95% confidence intervals adjusted by its baseline value for short-, mid-, and long-term follow-up. Abbreviations: m, number of
trials; nC, number of participants in the control arm; nI, number of participants in the intervention arm; short-, mid- and long-term follow-up,
measurements taken 2 and 3months, at 6 months and 12months post randomisation or entry to the trial, respectively; FFbHR, Hannover
functional ability questionnaire for measuring back-pain related functional limitations; RMDQ, Roland Morris disability questionnaire; PCS, physical
component scale of SF-12/36; MCS, mental component scale of SF-12/36. a The original scale was rescaled from 0 to 100 for graphical
representation purposes only. In order to obtain the estimated difference and its 95% confidence interval in its original scale, the value from
graph is multiplied by (maximum value/100). For example, the estimated difference for RMDQ at short-term follow-up was 5.47*24/100 = 1.31. b
One of the following instruments from each trial, where available, was chosen (in descending order): 1. individual VAS on average pain today. 2.
average pain over the past 1 week. 3. average pain over the past 2 weeks, average pain over the past 1 month 4. average pain over the past 3
months. 5. the individual item of the CPG pain intensity score (CPG-PS) that is equivalent to the VAS if it is available. 6. the summary score of the
CPG-PS or 7. the bodily pain domain of SF-12/36
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the greatest benefit on the FFbHR outcome at short-
term, with a treatment effect of 13.2 (95% CI, 10.56 to
15.77) compared to those with FFbHR≤54.2 and age >
60, for whom the treatment effect was 8.1 (95% CI, 5.47
to 10.80) (Fig. 3). For the short-term SF-12/36 MCS out-
come, those with greater baseline psychological distress
gained most benefit (3.5; 95% CI, 2.62 to 4.30) (Fig. 3)
from any therapist-delivered intervention. For the short-
term SF-12/36 PCS outcome, females with less psycho-
logical distress (MCS > 50.9) gained most benefit (4.7;
95% CI, 3.67 to 5.78) or those with less psychological
distress (MCS > 50.9) and worse physical disability
(PCS ≤ 40) gained more benefit from any therapist-
delivered intervention (4.9; 95% CI, 3.96 to 5.82)
(Fig. 3).
Recursive partitioning: pairwise comparisons
Analyses included between 496 and 3879 people (from
two to seven trials; Additional file 1: Appendix 3).
Active physical vs non-active usual care
No subgroups were identified for the active physical vs
non-active usual care comparison.
Passive physical vs non-active usual care (Additional file 1:
Appendix 4)
For the passive physical vs non-active usual care com-
parison for short-term FFbHR, those with more back
pain disability (FFbHR≤54.2) and younger (age ≤ 53)
gained most benefit from passive physical treatments
(16.7; 95% CI, 13.16 to 20.18). For the SF-12/36 MCS
outcome, those with greater psychological distress
(MCS ≤ 54.3) and greater physical disability (PCS ≤ 43.9)
gained most benefit (4.3; 95% CI, 3.39 to 5.15).
We found nine subgroups for the PCS outcome when
comparing passive physical vs usual care. These can be
classified into three subgroups; those with greater phys-
ical disability and younger, those with greater physical
disability but less psychological distress, and females
with greater physical disability but less psychological dis-
tress gained most benefit from passive physical
treatments.
Psychological vs non-active usual care (Additional file 1:
Appendix 5)
For the psychological vs non-active usual care compari-
sons, those with worse disability at baseline (RMDQ> 4)
gained most benefit from psychological treatment (1.7;
Fig. 2 Moderator analysis for short-term outcomes (change from baseline to short-term follow-up) between control (non-active usual care and
sham) and all intervention treatments with estimated interaction term and its 95% confidence interval. Abbreviations: RMDQ, Roland Morris
disability questionnaire; FFbHR, Hannover functional ability questionnaire for measuring back-pain related functional limitations; QALY, quality-
adjusted life-years. a estimate of the treatment effect for participants with positive belief (low fear avoidance) of fear avoidance belief was greater
as opposed to those with the negative attitude; b estimate of the treatment effect for participants with moderate belief of fear avoidance was
greater as opposed to those with the negative attitude; c estimate of the treatment effect for participants with positive attitude of
catastrophising (low catastrophising score) was greater as opposed to those with the negative attitude (high catastrophising score); d estimate of
the treatment effect for participants with moderate attitude of catastrophising was greater as opposed to those with the negative attitude;
e estimate of the treatment effect for participants with low risk of anxiety was less as opposed to those with the high risk; f estimate of the
treatment effect for participants with moderate risk of anxiety was less as opposed to those with the high risk; g estimate of the treatment effect
for participants with positive attitude of coping strategy (high coping score) was less as opposed to those with the negative attitude (low coping
score); h estimate of the treatment effect for participants with moderate attitude of coping strategy was less as opposed to those with the
negative attitude; i estimate of the treatment effect for participants with SF-12/36 MCS score lower than general norm (< 50) was less as opposed
to those with score at or above the general norm (≥50); j estimate of the treatment effect for male was less as opposed to female
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95% CI, 1.12 to 2.31) for the short-term disability
(RMDQ) outcome.
Sham control vs non-active usual care (Additional file 1:
Appendix 6)
For the sham control vs non-active usual care compari-
sons, those who were younger (age ≤ 65) or had greater
physical disability (PCS ≤ 42) gained most benefit (3.4;
95% CI, 1.80 to 5.04) and (3.1; 95% CI, 1.55 to 4.65), re-
spectively, from sham control on the SF-12/36 MCS
outcome.
Adaptive refinement by directed peeling: overall
comparison
Analyses included between 1365 and 5208 people (from
two to eight trials; Additional file 1: Appendix 2).
Categorical covariates such as gender and psycho-
logical states with three categories (anxiety, catastrophis-
ing and coping) were excluded from subgroup
identification with ARDP method because a split on
these categorical covariates would lead to a large propor-
tion of participants being removed. Additional file 1:
Appendix 7 shows the trajectory plot for the interaction
treatment effect against the size of the subgroup for
short-term (a) FFbHR, (b) RMDQ, (c) Pain, (d) PCS of
SF-12/36, (e) MCS of SF-12/36, and (f) EQ-5D. Treat-
ment effects generally increased as subpopulations get
smaller but the strong fluctuations for RMDQ (Add-
itional file 1: Appendix 7, figure (b)), Pain (Additional
file 1: Appendix 7, figure (c)) and PCS (Additional file 1:
Appendix 7, figure (d)) suggest that no subgroup would
gain greater improvement in these outcomes.
Table 3 shows the thresholds for selected sizes of the
subgroup for the short-term FFbHR found in Additional
file 1: Appendix 7, figure (a). The average treatment ef-
fect on the short-term FFbHR of approximately 90% of
the population (PCS < 48 and MCS < 72) was 8.5. The
average treatment effect increased by 8 units to 16.8 in a
subpopulation with FFbHR < 29, PCS < 68 and MCS <
57. However, the proportion of participants with such
great improvement is very small (approximately 10%).
Similarly, 10% of the population (PCS < 29 and MCS <
51) had a very large average treatment effect on the
short-term SF-12/36 MCS compared to 90% of the
Fig. 3 Treatment effect and its 95% confidence interval for each subgroup identified by the RP method for the short-term FFbHR, SF-12/36 MCS
and SF-12/36 PCS outcomes
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population (PCS < 48 and MCS < 72); 6.0 units compare
to 2.2 units (Additional file 1: Appendix 8), suggesting
that participants with more psychological distress would
gain greater improvement. It is interesting that in the
construction of subgroups, the disability scale, FFbHR,
did not seem to be an important covariate whereas the
functional scale of the SF-12/36 PCS suggested that
those with poor physical status would gain greater im-
provement. Population with low PCS and high RMDQ
at baseline (corresponding to poor disability and physical
status) also had greater improvement on short-term
health utility measured by EQ-5D (Additional file 1:
Appendix 9).
Adaptive refinement by directed peeling: pairwise
comparisons
Active physical vs non-active usual care
In this pairwise comparison, subgroup identification was
done for the short-termRMDQ outcome (Additional file
1: Appendix 3). The ARDP method failed to identify
subgroups that would gain greater improvement in treat-
ment effect.
Passive physical vs non-active usual care
This direct pairwise comparison included FFbHR, SF-12/
36 PCS and SF-12/36 MCS outcomes. Similar to the
overall analysis, there was no evidence of any subgroup
gaining greater treatment effect on the short-term SF-
12/36 PCS. Younger participants (< 55 years) with
FFbHR < 42 had the greatest treatment effect, 18.42, on
the short-term FFbHR. Younger participants (< 51 years)
with PCS < 44 (greater physical disability) and MCS < 38
(greater psychological distress) benefited more in short-
term SF-12/36 MCS (treatment effect 6.33) when given
passive physical treatment compare to non-active usual
care (result not shown).
Psychological vs non-active usual care
The direct pairwise comparison between psychological
and non-active usual care included only RMDQ, finding
no subgroup that would gain much treatment effect.
Sham control vs non-active usual care
Two trials had sham intervention (sham acupuncture)
and collected FFbHR and SF-12/36. There was no treat-
ment effect in different subgroups for the short-term SF-
12/36 PCS. Younger, poorer disability and physical limi-
tation, and more psychological distress (< 52 years,
FFbHR < 42, PCS < 45 and MCS < 52) participants had
greater treatment effect, 12.64, on the short-term
FFbHR. Similarly, they (age < 43, PCS < 37 and MCS <
52) had greater treatment effect, 7.86, on the short-term
SF-12/36 MCS, suggesting we may be able to identify
subgroups responding to sham treatments compared to
no treatment (result not shown).
Discussion
Current LBP treatments offer small to moderate average
effects [35], there is therefore, a desire to identify sub-
groups, targeting patients to treatments most likely to be
beneficial.
We have used two statistical methods to identify sub-
groups defined by participant’s presenting characteristics
where treatment effects vary in clinically meaningful
ways. In our overall comparison of all interventions with
control groups we found that females with low levels of
psychological distress gain the greatest benefit on the
SF12/36 physical component score from any
Table 3 Thresholds for selected sizes of the subgroup for the short-term FFbHR outcome as seen in Additional file 1: Appendix 8,
figure (a)
Subgroup size Age (<) FFbHR (<)
(0 to 100; 100 = best)
SF-12/36 PCS (<)
(0 to 100; 100 = best)
SF-12/36 MCS (<)
(0 to 100; 100 = best)
Treatment effect
0.001 37 29.17 33.62 28.93 91.29
0.102 91 29.17 67.75 56.82 16.79
0.200 54 54.17 43.62 72.11 13.74
0.308 62 54.17 67.75 72.11 12.72
0.400 62 70.83 40.45 60.35 11.32
0.509 67 62.50 67.75 72.11 10.36
0.602 91 75.00 40.45 60.35 9.96
0.702 91 75.00 47.59 60.35 9.14
0.808 91 100.00 47.59 60.35 8.59
0.906 91 100.00 47.59 72.11 8.47
Adapted with permission from: Patel S, Hee SW, Mistry D, Jordan J, Brown S, Dritsaki M, Ellard DR, Friede T, Lamb SE, Lord J, Madan J, Morris T, Stallard N, Tysall C,
Willis A, Underwood M, the Repository G. Programme Grants for Applied Research. Identifying back pain subgroups: developing and applying approaches using
individual patient data collected within clinical trials. Southampton (UK): NIHR Journals Library
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intervention compared to other participants. This pro-
vided proof of principle for our novel methods in this
dataset.
It is, however, the pairwise comparisons that are of
clinical importance We found the greatest benefit in
back pain disability from passive physical treatments
(acupuncture or manual therapy) is amongst those that
are young, with high levels of disability but low levels of
psychological distress.
It is, however, difficult to draw any concrete clinical
conclusions with regards to targeting treatments as the
effect sizes observed are unlikely to be clinically mean-
ingful and even the small effects sizes seen in the groups
that have done less well would still make the interven-
tion useful.
Other research
Since we started this work, an RCT testing the STarT
Back Screening Tool for risk stratification, which had a
positive result and was published and included in NICE
guidance [36]. This compared standard care to a risk
stratification tool that allocated participants to one of
three treatment packages delivered by specially trained
physiotherapists. The content of the physiotherapy and
differences between intervention and control physiother-
apists may have contributed to the effect size. The treat-
ment effect moderation of the STarT Back tool was not
tested. This trial, therefore, does not materially affect
our conclusions.
Further developments in risk stratification tools con-
tinue despite challenges of accuracy and application re-
ported by therapists [37]. Some argue for a more
multidimensional stratification approach, although our
results have not consistently supported this [38]. There
are other approaches that might be used to explore these
data to identify how participant characteristics might
moderate response to different treatments approaches.
This is beyond the scope of this current piece of work.
In 2019, after we had completed our work, an IPD
meta-analysis of exercise therapy for LBP was published
[7]. This work included data from 3514 people from 27
trials. The focus was on exercise interventions only, lim-
iting analysis to moderation effects of single variables,
and the inclusion of larger numbers of smaller trials
(average size 130) makes this work distinctly different
from the work presented here. The authors found some
exploratory evidence that those with less physically de-
manding jobs, or who use pain medication are more
likely to benefit from exercise therapy than other treat-
ments in the short term. Lower BMI was also reported
to improve outcomes from exercise. In our work, we
have focused on therapist-delivered interventions more
broadly including active physical, passive physical and
psychological treatments rather than just exercise
therapy. This has allowed us to include some large high
quality trials giving us a much larger overall dataset. The
challenge of small low quality studies being included
remains.
A 2020 IPD meta-analysis of acupuncture for chronic
pain included data from 20,827 people from 39 trials
and did not find a subgroup responding exceptionally
better to acupuncture [39]. Similarly, an IPD meta-
analysis of spinal manipulative therapy (SMT) for
chronic low back pain did not find a subgroup that
would gain greater benefit from SMT compared to other
treatments [40].
Strengths
Our large pooled repository with 9328 participants, un-
like many previous studies, provides sufficient statistical
power for subgroup analyses and may allow future ques-
tions in LBP to be addressed without large trials.
We have developed detailed and robust methods for
programming and coding of trials, which has been vital
in allowing the standardising, coding and pooling of tri-
als that have all come from varied and complex data sets
using different coding structures.
As both identified subgroups with very small interac-
tions effects, we feel confident that the statistical
methods are robust. We would be more concerned if the
methods reported substantially different findings.
Limitations
Despite our large initial dataset, many analyses used only
a small subset of the data because we were unable to
pool outcomes measuring the same domain to a com-
mon scale [12]. We are confident, however, that the
same domain is being measured in each trial.
We did not do a risk of bias assessment for included
studies. This would have been important for a review
reporting overall treatment effects; and appropriate tools
are available. However, for an IPD meta-analysis of this
nature exploring sub-group effects we are not aware of
any tool to assess risk of bias specifically in moderation effects.
The decision to group trials into active physical, pas-
sive physical, psychological, sham and control could be
questioned but was necessary for meaningful analyses.
Our approach was very carefully considered and agreed
by the research and lay team.
For our analyses, we used the mental and physical
component scores of the SF-12/36 rather than their
eight domain scores. This because we considered these
were more clinically relevant as outcomes and to avoid
further complicating our analyses, and their interpret-
ation, by adding additional variables. We cannot exclude
that an analysis using the individual domain scores as
explanatory variables rather than the component scores
might have produced a different outcome.
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Conclusion
A large pooled database provided good statistical power
for our analyses. In a pooled analysis of any treatment
against usual care at baseline, pain, disability, age, gen-
der, and psychological state all showed at least weak
evidence of effect moderation on some outcomes. We
separated our data into three broad treatment types; ac-
tive physical, passive physical, and psychological for sub-
group analyses. No sub-groups were identified who
would benefit more from active physical treatments. Pas-
sive physical treatments were most likely to help people
who were younger with higher levels of disability and
low levels of psychological distress. Psychological treat-
ments were more likely to help those with severe disabil-
ity. Despite this, the clinical importance of identifying
these subgroups is limited. The sizes of sub-groups more
likely to benefit and the additional effect sizes observed
are small. Positive treatment effects are also seen in
groups less likely to benefit. Our analysis indicates no
evidence to support the use of sub-grouping to inform
treatment choices for people with low back pain. Our
methodological approaches worked well and may have
applicability in other clinical areas.
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